SEC Form DFiling only, no announcement found
Turn Therapeutics, based in Westlake Village, CA, reported $1,650,000 sold in a private offering of equity, with the first sale on August 14, 2026, in a Form D filed with the SEC on August 26, 2026. The filing says 8 investors have already invested. The total offering is stated as Indefinite.
Legal name on the filing: Turn Therapeutics Inc.. Formerly Global Health Solutions, Inc.
| Amount sold | $1,650,000Basis: Form D total amount sold, as of the filing of August 26, 2026. Not the announced round size. |
|---|---|
| Total offering | IndefiniteThe most the company may sell under this offering. Not money raised. |
| Securities offered | Equity |
| Exemption claimed | Rule 506(b) |
| Date of first sale | August 14, 2026 |
| Investors already invested | 8 |
| Non-accredited investors | None |
| Minimum investment accepted | $15,000 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Westlake Village, CA |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 2023016 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Bradley Burnam | Executive Officer, Director | None linked |
| Zuraiz Chaudhary | Executive Officer | None linked |
| Martin William Dewhurst | Director | None linked |
| Andrew Gengos | Director | None linked |
| Arthur F Golden | Director | None linked |
| Kent Kester | Director | None linked |
| Neilesh Shailesh Ghodadra | Executive Officer, Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Aug 26, 2026 | D (original) | $1,650,000 | Indefinite |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Turn Therapeutics: SEC Form D deal record", https://vcbeast.com/deals/turn-therapeutics-form-d-2026-08-14. Source: SEC EDGAR, accession 0002023016-26-000001.